Diez-Domingo J, Saez-Llorens X, Rodriguez-Weber MA, Epalza C, et al. Safety and immunogenicity of a ChAd155-vectored RSV vaccine (ChAd155-RSV) in healthy RSV-seropositive children 12-23 months of age. J Infect Dis 2022 Dec 9:jiac481. doi: 10.1093.
PMID: 36484484